AAAAAA
Results:
1-11
|
Results: 11
Authors:
Calogero, A
Arcella, A
De Gregorio, G
Porcellini, A
Mercola, D
Liu, CT
Lombari, V
Zani, M
Giannini, G
Gagliardi, FM
Caruso, R
Gulino, A
Frati, L
Ragona, G
Citation: A. Calogero et al., The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas, CLIN CANC R, 7(9), 2001, pp. 2788-2796
Authors:
Chisesi, T
Polistena, P
Contu, A
Coser, P
Indrizzi, L
Leoni, P
Majolino, I
Porcellini, A
Salvagno, L
Zambaldi, G
Rizzoli, V
Congiu, AM
Santini, G
Citation: T. Chisesi et al., Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-Hodgkin's lymphoma: An effective and non toxic therapeutic alternative for adult and elderly patients, LEUK LYMPH, 41(1-2), 2001, pp. 125-136
Authors:
Squitieri, F
Cannella, M
Porcellini, A
Brusa, L
Simonelli, M
Ruggieri, S
Citation: F. Squitieri et al., Short-term effects of olanzapine in Huntington disease, NEUROPS NEU, 14(1), 2001, pp. 69-72
Authors:
Quadro, L
Fattoruso, O
Cosma, MP
Verga, U
Porcellini, A
Libroia, A
Colantuoni, V
Citation: L. Quadro et al., Loss of heterozygosity at the RET protooncogene locus in a case of multiple endocrine neoplasia type 2A, J CLIN END, 86(1), 2001, pp. 239-244
Authors:
Santini, G
Coser, P
Congiu, AM
Salvagno, L
De Souza, C
Sertoli, MR
Olivieri, A
Chisesi, T
Rubagotti, A
Truini, M
Contu, A
Porcellini, A
Zambaldi, G
Nati, S
Marino, G
Rizzoli, V
Citation: G. Santini et al., VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group, HAEMATOLOG, 85(2), 2000, pp. 160-166
Authors:
Enea, I
De Paolis, P
Porcellini, A
Piras, O
Savoia, C
Russo, R
Giliberti, R
Gigante, B
Rubattu, S
Conte, G
Ganten, D
Volpe, M
Citation: I. Enea et al., Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat, BAS R CARD, 95(2), 2000, pp. 84-92
Authors:
Feliciello, A
Gallo, A
Mele, E
Porcellini, A
Troncone, G
Garbi, C
Gottesman, ME
Avvedimento, EV
Citation: A. Feliciello et al., The localization and activity of cAMP-dependent protein kinase affect cellcycle progression in thyroid cells, J BIOL CHEM, 275(1), 2000, pp. 303-311
Authors:
Tassi, V
Di Cerbo, A
Porcellini, A
Papini, E
Cisternino, C
Crescenzi, A
Scillitani, A
Pizzuti, A
Ratti, A
Trischitta, V
Avvedimento, VE
Fenzi, G
De Filippis, V
Citation: V. Tassi et al., Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goiters, THYROID, 9(4), 1999, pp. 353-357
Authors:
De Paolis, P
Porcellini, A
Gigante, B
Giliberti, R
Lombardi, A
Savoia, C
Rubattu, S
Volpe, M
Citation: P. De Paolis et al., Modulation of the AT(2) subtype receptor gene activation and expression bythe AT(1) receptor in endothelial cells, J HYPERTENS, 17(12), 1999, pp. 1873-1877
Authors:
Paolillo, M
Feliciello, A
Porcellini, A
Garbi, C
Bifulco, M
Schinelli, S
Ventra, C
Stabile, E
Ricciardelli, G
Schettini, G
Avvedimento, EV
Citation: M. Paolillo et al., The type and the localization of cAMP-dependent protein kinase regulate transmission of cAMP signals to the nucleus in cortical and cerebellar granule cells, J BIOL CHEM, 274(10), 1999, pp. 6546-6552
Authors:
Gigante, B
Piras, O
De Paolis, P
Porcellini, A
Natale, A
Volpe, M
Citation: B. Gigante et al., Role of the angiotensin II AT(2)-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats, J HYPERTENS, 16(12), 1998, pp. 2039-2043
Risultati:
1-11
|